Japan Tissue Engineering Reports Q2 Financial Results

Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.

Japan Tissue Engineering Co., Ltd. reported a decline in net sales and net income for the second quarter of FY2024 compared to the previous year, with net sales down by 6.8% and net income per share falling to -5.55 yen. Despite these setbacks, the company maintains a strong equity ratio of 90.3%, indicating financial stability. Looking ahead, the company forecasts a modest recovery in net sales and income for the full fiscal year, although net income is expected to decrease by 39.2% compared to the previous year.

For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.